Abstract
Whether warfarin can bring good outcomes for patients with atrial fibrillation (AF) and chronic kidney disease (CKD) is uncertain. To better answer this question, we performed a meta-analysis to evaluate the safety and efficacy of warfarin in patients with AF and end-stage renal disease (ESRD) and
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
